132 related articles for article (PubMed ID: 3136464)
21. Platelet MAO activity in clinical subtypes of depression and DST suppression.
Poirier MF; Lôo H; Mitrani N; Benkelfat C; Askienazy S; Le Fur G
Acta Psychiatr Scand; 1987 May; 75(5):456-63. PubMed ID: 3604729
[TBL] [Abstract][Full Text] [Related]
22. Neuroendocrine interrelationships in major depressive disorder.
Targum SD; Sullivan AC; Byrnes SM
Am J Psychiatry; 1982 Mar; 139(3):282-6. PubMed ID: 6800269
[TBL] [Abstract][Full Text] [Related]
23. Platelet MAO activity and the dexamethasone suppression test in bipolar depression.
Bagdy G; Rihmer Z; Frecska E; Szádóczky E; Arató M
Psychoneuroendocrinology; 1986; 11(1):117-20. PubMed ID: 3704065
[TBL] [Abstract][Full Text] [Related]
24. [The dexamethasone suppression test and TRH stimulation test in endogenous depressives, schizophrenics, and normal volunteers].
Ho SL; Lu RB; Ferng HK; Lin TY
Zhonghua Yi Xue Za Zhi (Taipei); 1988 Apr; 41(4):271-80. PubMed ID: 3141027
[No Abstract] [Full Text] [Related]
25. Association between high platelet MAO activity and response to MAO inhibitor in depressed bipolars: case reports.
Rihmer Z; Arató M; Bagdy G
Pharmacopsychiatria; 1983 Jul; 16(4):119-20. PubMed ID: 6634937
[TBL] [Abstract][Full Text] [Related]
26. DST and TRH stimulation test in mood disorder subtypes.
Levy AB; Stern SL
Am J Psychiatry; 1987 Apr; 144(4):472-5. PubMed ID: 3105335
[TBL] [Abstract][Full Text] [Related]
27. Monoamine oxidase and cortisol response in depression and schizophrenia.
Pandey GN; Sharma RP; Janicak PG; Davis JM
Psychiatry Res; 1992 Oct; 44(1):1-8. PubMed ID: 1461943
[TBL] [Abstract][Full Text] [Related]
28. Dexamethasone suppression test and TRH test in endogenous depression.
Aggernaes H; Kirkegaard C; Krog-Meyer I; Kijne B; Larsen JK; Laursen AL; Lykke-Olesen L; Mikkelsen PL; Rasmussen S; Bjørum N
Acta Psychiatr Scand; 1983 Apr; 67(4):258-64. PubMed ID: 6407280
[TBL] [Abstract][Full Text] [Related]
29. Endocrine responses after thyrotrophin-releasing hormone stimulation and dexamethasone suppression tests in the major depressive syndrome.
Aalbers C; Taljaard JJ; Gagiano CA
S Afr Med J; 1986 Oct; 70(8):464-8. PubMed ID: 3095937
[TBL] [Abstract][Full Text] [Related]
30. The TRH stimulation test and the dexamethasone suppression test in depression.
Dam H; Mellerup ET; Rafaelsen OJ
Psychiatry Res; 1986 Apr; 17(4):309-16. PubMed ID: 3086912
[TBL] [Abstract][Full Text] [Related]
31. Classification of patients with affective disorders using platelet monoamine oxidase activity, serum melatonin and post-dexamethasone cortisol.
Wahlund B; Sääf J; Wetterberg L
Acta Psychiatr Scand; 1995 May; 91(5):313-21. PubMed ID: 7639087
[TBL] [Abstract][Full Text] [Related]
32. Platelet MAO activity and age at onset of depression in elderly depressed women.
Alexopoulos GS; Lieberman KW; Young RC; Shamoian CA
Am J Psychiatry; 1984 Oct; 141(10):1276-8. PubMed ID: 6486267
[TBL] [Abstract][Full Text] [Related]
33. Specificity of the DST and the TRH test for major depression in alcoholics.
Dackis CA; Bailey J; Pottash AL; Stuckey RF; Extein IL; Gold MS
Am J Psychiatry; 1984 May; 141(5):680-3. PubMed ID: 6424482
[TBL] [Abstract][Full Text] [Related]
34. Dexamethasone suppression test, TRH test and Newcastle II depression rating in the diagnosis of depressive disorders.
Larsen JK; Bjørum N; Kirkegaard C; Aggernaes H; Krog-Meyer I; Lund-Laursen AM; Mikkelsen PL
Acta Psychiatr Scand; 1985 May; 71(5):499-505. PubMed ID: 3925727
[TBL] [Abstract][Full Text] [Related]
35. The dexamethasone suppression test and thyroid stimulating hormone response to TRH in RDC schizoaffective patients.
Sauer H; Koehler KG; Sass H; Hornstein C; Minne HW
Eur Arch Psychiatry Neurol Sci; 1984; 234(4):264-7. PubMed ID: 6441714
[TBL] [Abstract][Full Text] [Related]
36. The dexamethasone suppression test and thyrotropin-releasing hormone stimulation test in posttraumatic stress disorder.
Kosten TR; Wahby V; Giller E; Mason J
Biol Psychiatry; 1990 Oct; 28(8):657-64. PubMed ID: 2122916
[TBL] [Abstract][Full Text] [Related]
37. Platelet MAO activity in anorexia nervosa patients with and without a major depressive disorder.
Biederman J; Rivinus TM; Herzog DB; Ferber RA; Harper GP; Orsulak PJ; Harmatz JS; Schildkraut JJ
Am J Psychiatry; 1984 Oct; 141(10):1244-7. PubMed ID: 6486260
[TBL] [Abstract][Full Text] [Related]
38. Unreliability of TRH test but not dexamethasone suppression test as a marker of depression in chronic vasculopathic patients.
Marchesi C; Silvestrini C; Ponari O; Volpi R; Chiodera P; Coiro V
Biol Psychiatry; 1996 Oct; 40(7):637-41. PubMed ID: 8886297
[TBL] [Abstract][Full Text] [Related]
39. Psychotic and nonpsychotic depressions: II. Platelet MAO activity, plasma catecholamines, cortisol, and specific symptoms.
Schatzberg AF; Rothschild AJ; Langlais PJ; Lerbinger JE; Schildkraut JJ; Cole JO
Psychiatry Res; 1987 Feb; 20(2):155-64. PubMed ID: 3575560
[TBL] [Abstract][Full Text] [Related]
40. Toward a biochemical classification of depressive disorders, VI: Platelet MAO activity and clinical symptoms in depressed patients.
Gudeman JE; Schatzberg AF; Samson JA; Orsulak PJ; Cole JO; Schildkraut JJ
Am J Psychiatry; 1982 May; 139(5):630-3. PubMed ID: 7072851
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
